Gorging and plasma HDL-cholesterol - The Ramadan model

被引:61
|
作者
Maislos, M [1 ]
Abou-Rabiah, Y
Zuili, I
Iordash, S
Shany, S
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr Kupat Holim,Toor Inst, Dept Med,Atherosclerosis Prevent & Treatment Unit, Beer Sheva, Israel
[2] Kupat Holim Rahat Community Clin, Rahat, Israel
关键词
gorging; nibbling; high density lipoprotein; Ramadan;
D O I
10.1038/sj.ejcn.1600526
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objectives: To evaluate the effect of a single evening meal (gorging) on plasma lipids and lipoproteins in normal individuals observing the Ramadan Fast. During the Ramadan month, Muslims refrain from food and liquids during the day and eat a large meal after sundown. Design: Sequential measurement of plasma lipids and lipoproteins in Muslims observing the Ramadan Fast and non-fasting individuals. Setting: The study was conducted in the Bedouin town of Rahat, in the northern Negev area of Israel. Subjects: Twenty-two healthy subjects who fasted during Ramadan and 16 non-fasting laboratory workers, were studied before Ramadan, at week 1, 2 and 4 of the Ramadan month, and again four weeks after the end of Ramadan. Results: Plasma high-density lipoprotein cholesterol (HDL) rose significantly (P < 0.001) at the week 4 measurement, returning to basal levels 4 weeks after the end of Ramadan. Total cholesterol (TC), triglycerides (TG, low-density lipoprotein cholesterol (LDL), very-low density lipoprotein cholesterol (VLDL), and lipoprotein (a) [Lp(a)] did not change significantly. Conclusions: Plasma HDL increased by 23% after four weeks of gorging. The dietary change did not affect the composition of other lipoproteins, such as LDL, VLDL or Lp(a), other plasma biochemical parameters, or BMI. Prolonged gorging, well tolerated by all individuals, is a very effective non-pharmacological method to increase plasma HDL-cholesterol.
引用
收藏
页码:127 / 130
页数:4
相关论文
共 50 条
  • [41] Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting
    Cziraky, Mark J.
    Watson, Karol E.
    Talbert, Robert L.
    JOURNAL OF MANAGED CARE PHARMACY, 2009, 14 (08): : S3 - S28
  • [42] Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program
    Bertolin-Boronat, Carlos
    Merenciano-Gonzalez, Hector
    Marcos-Garces, Victor
    Martinez-Mas, Maria Luz
    Alberola, Josefa Ines Climent
    Perez, Nerea
    Lopez-Bueno, Laura
    Esteban-Argente, Maria Concepcion
    Valls Reig, Maria
    Benito, Ana Arizon
    Rubio, Alfonso Paya
    Rios-Navarro, Cesar
    de Dios, Elena
    Gavara, Jose
    Sanchis, Juan
    Bodi, Vicente
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2025, 26 (01)
  • [43] Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level
    Palatini, Paolo
    Virdis, Agostino
    Masi, Stefano
    Mengozzi, Alessandro
    Casiglia, Edoardo
    Tikhonoff, Valerie
    Cicero, Arrigo F. G.
    Ungar, Andrea
    Parati, Gianfranco
    Rivasi, Giulia
    Salvetti, Massimo
    Barbagallo, Carlo M.
    Bombelli, Michele
    Dell'Oro, Raffaella
    Bruno, Berardino
    Lippa, Luciano
    D'Elia, Lanfranco
    Masulli, Maria
    Verdecchia, Paolo
    Reboldi, Gianpaolo
    Angeli, Fabio
    Mallamaci, Francesca
    Cirillo, Massimo
    Rattazzi, Marcello
    Cirillo, Pietro
    Gesualdo, Loreto
    Mazza, Alberto
    Giannattasio, Cristina
    Maloberti, Alessandro
    Volpe, Massimo
    Tocci, Giuliano
    Iaccarino, Guido
    Nazzaro, Pietro
    Galletti, Ferruccio
    Ferri, Claudio
    Desideri, Giovambattista
    Viazzi, Francesca
    Pontremoli, Roberto
    Muiesan, Maria Lorenza
    Grassi, Guido
    Borghi, Claudio
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (02) : 323 - 330
  • [44] Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis
    Lee, Wen-Chin
    Chen, Jin-Bor
    Moi, Sin-Hua
    Yang, Cheng-Hong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
    Srivastava, Neelam
    Cefalu, Angelo B.
    Averna, Maurizio
    Srivastava, Rai A. K.
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [46] How to control residual cardiovascular risk despite statin treatment: Focusing on HDL-cholesterol
    Lim, Soo
    Park, Yae Min
    Sakuma, Ichiro
    Koh, Kwang Kon
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 166 (01) : 8 - 14
  • [47] Effects of Intake of Soy and Non-Soy Legume on Serum HDL-Cholesterol Levels
    Yanai, Hidekatsu
    Tada, Norio
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 8 (05) : 83 - 86
  • [48] Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness
    van den Bogaard, Bas
    Holleboom, Adriaan G.
    Duivenvoorden, Raphal
    Hutten, Barbara A.
    Kastelein, John J. P.
    Hovingh, G. Kees
    Kuivenhoven, Jan Albert
    Stroes, Erik S. G.
    van den Born, Bert-Jan H.
    ATHEROSCLEROSIS, 2012, 225 (02) : 481 - 485
  • [49] CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or Both
    Nicholls, Stephen J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (02) : 297 - 300
  • [50] Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
    Paavola, Timo
    Kuusisto, Sanna
    Jauhiainen, Matti
    Kakko, Sakari
    Kangas-Kontio, Tiia
    Metso, Jari
    Soininen, Pasi
    Ala-Korpela, Mika
    Bloigu, Risto
    Hannuksela, Minna L.
    Savolainen, Markku J.
    Salonurmi, Tuire
    PLOS ONE, 2017, 12 (02):